Bukwang Pharmaceutical Co., Ltd. (003000.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 373.45B |
| Enterprise Value | 414.58B |
| P/E Ratio | 28.73 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 1.98 |
| Price/Book Ratio | 1.18 |
| Enterprise/Revenue | 1.82 |
| Enterprise/EBITDA | 19.92 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.06 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 200.71B |
| Revenue/Share | 2,061.59 |
| Gross Profit | 95.72B |
| EBITDA | 19.65B |
| Net Income | 12.57B |
| Diluted EPS | 152 |
Balance Sheet
| Total Cash | 209.42B |
| Total Cash/Share | 2,151.37 |
| Total Debt | 80.65B |
| Total Debt/Equity | 0.24 |
| Current Ratio | 2.55 |
| Book Value Per Share | 3,428.86 |
Price History
| 52-Week Change | 11.77 |
| 52-Week High | 9,890 |
| 52-Week Low | 3,200 |
| Moving Average 50 Days | 5,899 |
| Moving Average 200 Days | 4,764.4 |
Statistics
| Average Volume | 2.33M |
| Shares Outstanding | 98.66M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 125 |
| Trailing Annual Dividend Yield | 3.1 |
| Payout Ratio | 0.35 |
| Last Split Factor | 11:10 |
| Last Split Date | December 29, 2020 |
AD
